The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Eton Pharmaceuticals, Inc. insider acquisitions

Company CIK 0001710340 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
ETON · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
90-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Exercise / conversionCode MCommon StockNon-derivative · Currency not specified1Not applicable1

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Krempa DavidKrempa DavidGruber James R.Gruber James R.Krempa David · October 2, 2026 · Exercise / conversion · Common StockKrempa David · December 11, 2025 · Stock award · Restricted Stock UnitsGruber James R. · December 11, 2025 · Stock award · Restricted Stock UnitsDec 11, 2025Oct 2, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 2 of 2 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 2, 2026Eton Pharmaceuticals, Inc.Common StockKrempa DavidExercise / conversion
Dec 11, 2025Eton Pharmaceuticals, Inc.Restricted Stock UnitsKrempa DavidStock award
Dec 11, 2025Eton Pharmaceuticals, Inc.Restricted Stock UnitsGruber James R.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

ETON · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Krempa DavidChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M10,522Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Krempa DavidChief Business Officer
Stock awardRestricted Stock UnitsDerivative security · Code A5,3000Value: 0Currency not specifiedView ↗
Trade:
Gruber James R.Chief Financial Officer
Stock awardRestricted Stock UnitsDerivative security · Code A5,5020Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →